Since its establishment in 2006, Unitaid has received over $US 3.8 billion in contributions from donors.

Unitaid’s donors are: Brazil, Chile, France, Japan, Norway, the Republic of Korea, Spain, the United Kingdom and the Bill & Melinda Gates Foundation.


As part of Unitaid’s response to the COVID-19 pandemic and leadership of the ACT-Accelerator, the organization received additional resources from Canada, Germany, Italy, Portugal, and Wellcome.

We receive money from donors

We invest it in promising health projects

We set stringent targets and closely monitor grant performance

We measure public health impact and savings generated

To better target our funds in future


Two-year old Kamaragi's life was saved in Uganda, thanks to effective treatment with injectable artesunate (Image: Pierre Hugo/MMV)

We discovered that the best new treatments for severe malaria were not getting to those who need them. Severe malaria is a life-threatening condition that must be treated within hours to save patients from dying. Children are particularly at risk.

Injectable artesunate is a highly effective treatment for severe malaria; preferable and more effective than quinine. It can buy precious time for patients to reach clinics for full treatment. We found that this medicine was not being adopted on a large-scale by national health programmes.

We invested US $18 million to improve the availability of injectable artesunate in six countries, lowering prices and reaching more patients. It’s a cost-effective intervention, at less than US $4 per Disability Adjusted Life Year (DALY).

Our estimates suggest that by switching to injectable artesunate, funding partners and governments could generate an additional $10 in return for every dollar spent.

Learn More
Partners How We Work
Donors How We Work
Countries How We Work
Grantees How We Work

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.